Arrowstreet Capital, Limited Partnership Elanco Animal Health Inc Transaction History
Arrowstreet Capital, Limited Partnership
- $114 Billion
- Q2 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 23,114 shares of ELAN stock, worth $326,369. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,114Holding current value
$326,369% of portfolio
0.0%Shares
18 transactions
Others Institutions Holding ELAN
# of Institutions
438Shares Held
484MCall Options Held
3.14MPut Options Held
1.29M-
Dodge & Cox San Francisco, CA83.6MShares$1.18 Billion0.76% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$742 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.4MShares$698 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD28.1MShares$396 Million0.05% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$329 Million0.01% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.69B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...